CAS No.: | 117928-94-6 |
---|---|
Formula: | C18h31n5o6 |
EINECS: | N/a |
Type: | Pharmaceutical Intermediates |
Appearance: | Powder |
Quality: | Refined |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product name |
Glyx 13 |
Appearance | White powder |
Purity | 99% |
Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
Shelf Life | 24 Months |
Rapastinel (Glyx 13) is a NMDA receptor modulator with glycine-site partial agonist properties. It is a robust cognitive
enhancer and shows rapid and long-lasting antidepressant properties in both animal models and in humans.
Rapastinel was derived from a monoclonal antibody, B6B21, is a tetrapeptide (threonine-proline-proline-threonine-amide)
obtained from amino acid sequence information obtained from sequencing one of the hypervariable regions of the light
chain of B6B21. The in-vivo and in-vitro pharmacology of rapastinel was examined.
Suppliers with verified business licenses